Valchlor
Showing 1 - 7 of 7
Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)
Not yet recruiting
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides
- Hypericin
- Mechlorethamine Topical Gel
-
Fairport, New YorkRochester Skin Lymphoma Medical Group
Nov 20, 2023
Skin Irritation Trial in Cleveland (4 , 4 Vitamin D, Valchlor)
Completed
- Skin Irritation
- 4 placebo
- +2 more
-
Cleveland, OhioUniversity Hospitals
Dec 6, 2021
Lichen Planopilaris Trial in Jacksonville (Mechlorethamine 0.016% Top Gel)
Completed
- Lichen Planopilaris
- Mechlorethamine 0.016% Top Gel
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 26, 2021
Mycosis Fungoides Trial in Leiden (Chlormethine)
Recruiting
- Mycosis Fungoides
-
Leiden, NetherlandsCentre for Human Drug Research
Mar 29, 2022
Mycosis Fungoides Trial in Philadelphia (Mechlorethamine Hydrochloride Gel, Total Skin Electron Beam Radiation Therapy)
Withdrawn
- Mycosis Fungoides
- Mechlorethamine Hydrochloride Gel
- Total Skin Electron Beam Radiation Therapy
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 25, 2018
Mycosis Fungoides, Cutaneous T-cell Lymphoma Trial (Total skin electron beam therapy (TSEBT), mechlorethamine gel 0.016%)
Unknown status
- Mycosis Fungoides
- Cutaneous T-cell Lymphoma
- Total skin electron beam therapy (TSEBT)
- mechlorethamine gel 0.016%
- (no location specified)
Aug 29, 2016